Moderate-to-Severe Plaque Psoriasis Study B

People who are 18+ with chronic plaque-type psoriasis for at least 6 months, may qualify to receive investigational medication (active drug or placebo). Participants must be 18 years of age or older with moderate-to-severe plaque psoriasis at the time of study entry.

The length of study participation for Part B will last up to 40 weeks and include 15 visits to the study centre.

Participants will receive reimbursement for expenses associated with study visits.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more